HLA-DNA typing using PCR-SSOP and PCR-DCP methods was performed in 85 patients with
Takayasu arteritis and 492 healthy controls who had been typed for HLA by serological method. Frequencies of
HLA-B52 (B*5201) and B39 (B*3901 and B*3902) were significantly increased in the patients. Frequency of
HLA-DRB1*1502 was also increased but it was suggested to be a reflection of its linkage disequilibrium with B52. Association of
HLA-B52 and B39 with seven clinical manifestations--
pulmonary infarction,
ischemic heart disease,
aortic regurgitation, systemic
hypertension, renal artery
stenosis,
cerebrovascular disease, and visual disturbance--in 132 HLA-typed patients with
Takayasu arteritis was studied. In
HLA-B52 positive TA patients,
aortic regurgitation (vs B52(-)-B39(+), OR=3.8, P<0.05, vs B52(-)-B39(-), OR=5.49, P<0.001),
ischemic heart disease (vs B52(-)-B39(+), OR=12.05, P<0.05, vs B52(-)-B39(-), OR=2.85, P<0.05), and
pulmonary infarction (vs B52(-)-B39(+), OR=5.74, P<0.03) were found to be significantly prevalent. On the other hand, in
HLA-B39 positive TA patients, frequency of
renal artery stenosis was significantly increased (vs B52(+)-B39(-), OR=12.14, P<0.001, vs B52(-)-B39(-), OR=5.21, P<0.03). These observations have suggested that
HLA-B52 molecule and B39 molecule would contribute to different clinical manifestations by binding different antigenic
peptides to cause
inflammations. Thus
HLA-B molecule may play an important role in pathogenesis or determining clinical manifestations of
Takayasu arteritis.